Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Hepatocellular 61Stomach Neoplasms 46Carcinoma, Non-Small-Cell Lung 37Colorectal Neoplasms 24Esophageal Squamous Cell Carcinoma 19Lung Neoplasms 12Rectal Neoplasms 11Nasopharyngeal Carcinoma 11Esophageal Neoplasms 11Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Pancreatic Neoplasms 7Neoplasm Metastasis 7Cholangiocarcinoma 6Uterine Cervical Neoplasms 5Small Cell Lung Carcinoma 5Liver Neoplasms 5Triple Negative Breast Neoplasms 4Recurrence 4Endometrial Neoplasms 4Colonic Neoplasms 4Carcinoma, Renal Cell 4Solid Tumor 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Extranodal NK-T-Cell 3Colorectal Cancer Metastatic 3Carcinoma 3Breast Neoplasms 3Advanced Solid Tumors 3Advanced Solid Tumor 3

Interventions

nintedanib 2durvalumab 2Radiotherapy 2Immunotherapy 2tislelizumab 1sugemalimab 1sintilimab 1pembrolizumab 1camrelizumab 1beclomethasone 17-monopropionate 1aumolertinib 1atezolizumab 1apatinib 1Tomography, Emission-Computed, Single-Photon 1Surveys and Questionnaires 1Respiratory Function Tests 1Prednisone 1Nivolumab 1Nicorandil 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1Hyperbaric Oxygenation 1Exercise Test 1Esophagectomy 1Enalapril 1Disulfides 1Dexamethasone 1Cisplatin 1Breath Holding 1Angiogenesis Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Pneumonitis × sintilimab × Clear all
NCT06031597 2023-09-13

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Zhejiang Cancer Hospital

Phase 3 Unknown
105 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡